An observational study in Schizophrenia, sponsored by King's College London. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-05.
Sponsored by King's College London · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 20 studies in Schizophrenia by King's College London — 8 open to participants now, 8 under way, none of them phase 3. Schizophrenia · King's College London.
Among the 20 studies in Schizophrenia by King's College London, this one is one of 2 that started in 2024, is one of 4 observational ones, and was the 12th registered.
3,574 studies on the registry are indexed under Schizophrenia; 494 are open to participants now.
Browse Schizophrenia studies →8 of the 20 studies in Schizophrenia by King's College London are open now, in 3 countries. Recruiting first, the newest first:
King's College London · Sites in United Kingdom
Ages 18–65 · Healthy volunteers
King's College London · Sites in United Kingdom
Ages 18–65
King's College London · Sites in United Kingdom
Ages 18+ · Healthy volunteers
King's College London · Sites in United Kingdom
Ages 18+
King's College London · Sites in Ethiopia, India
Ages 18+
By country, each count listing its studies:
Of the 333 Schizophrenia studies recruiting now, 63 (19%) set no upper age limit and 258 (77%) stop at 75 or younger; 42 take children under 18; 83 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 2 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 75 is below the median of 178 across 508 observational studies indexed under Schizophrenia.
Median enrollment 33 across the 16 interventional studies, 111 across the 4 observational. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
King's College London is the lead sponsor of 524 studies on the registry; 130 are open to participants now.
2 of the studies in Schizophrenia by King's College London that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06957808King's College LondonInvestigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia | 2027-01-20 |
| NCT07939347King's College LondonAVATAR Therapy for Distressing Voices in India and Ethiopia | 2027-09-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 20 studies in Schizophrenia by King's College London, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this case-control study is to compare brain glutamate, glucose utilisation, lactate production and brain activity in healthy volunteers and people with a diagnosis of schizophrenia.
It investigates the following main questions:
Whether, compared to healthy volunteers, participants with schizophrenia show:
Participants will be asked to have a screening visit, a MRI brain scan and a PET-MRI brain scan.
healthy volunteers - community sample people with a diagnosis of schizophrenia - clinical mental health teams.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Healthy volunteer group:
1. No history of psychiatric illness, as assessed on the Mini neuropsychiatric Interview (MINI).
Treatment responsive schizophrenia group:
Treatment-resistant schizophrenia group:
Exclusion Criteria:
All participants:
2. Diabetes or history of taking an antidiabetic medication 3. Presence of to MRI at 7 Tesla, including metallic or electronic implants and dental wires.
4. Severe claustrophobia prohibiting participation on PET or MRI 5. Body size above the comfortable limits for the MRI scanner. 6. Previous participation in research or clinical procedure/s involving ionising radiation, which, including the current study, would result in total radiation exposure >=10mSv within 12 months 7. History of head injury resulting in loss of consciousness for > 5 minutes 8. Meeting ICD-11 criteria for organic mental disorder (F00-F09) 9. Meeting ICD-11 criteria for mental and behavioural disorders due to psychoactive substance use (F10-F19) 10. With exclusion of nicotine or cannabis, meeting ICD-11 criteria for psychoactive substance dependence 11. Participation in clinical trial investigating any pharmacological agent other than a licensed antipsychotic compound in the last month.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Procedure: MRI scan · Procedure: PET-MR scan
Procedure: MRI scan · Procedure: PET-MR scan
Procedure: MRI scan · Procedure: PET-MR scan
7 Tesla MRI scan
18F-fluorodeoxyglucose PET-MR scan
Brain glucose utilisation
Measured using fully quantitative 18F-fluorodeoxyglucose PET (CMRglc)
Time frame: 1 day
Glutamate - anterior cingulate cortex
Glutamate and glutamine measured using magnetic resonance spectroscopy at 7 Tesla
Time frame: 1 day
Lactate - visual cortex
Measured using magnetic resonance spectroscopy at 7 Tesla at rest and during visual stimulation
Time frame: 1 day
Cerebral blood flow
Measured using arterial spin labelling, 3 Tesla MRI
Time frame: 1 day
Cortical network activity
Network activity / connectivity as measured using fMRI at 3 Tesla
Time frame: 1 day
Plan to share: Yes — After the end of the study pseudoanonymised data will be available to other researchers.
Supporting information: Study protocol
Time frame: After the primary analyses are completed and published.
No publications or documents are linked to this record.
Started Mar 2024 (actual). Primary completion is estimated for Dec 2027, 45 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.